EP2964641
CRYSTALLINE FORM HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTALLINE FORM AS ACTIVE INGREDIENT
:
EP einkaleyfi: Þýðing ekki lögð inn:
24.6.2013:
13.3.2019:
13736983.1
:
23.6.2033
:
CRYSTALLINE FORM HAVING SPECIFIC CRYSTAL HABIT AND PHARMACEUTICAL COMPOSITION CONTAINING THIS CRYSTALLINE FORM AS ACTIVE INGREDIENT
24.6.2013
13.3.2019
:
Pola Pharma Inc.:
8-9-5, Nishi-gotanda, 141-0031, Shinagawa-kuTokyo, JP
:
Nihon Nohyaku Co., Ltd.:
19-8, Kyobashi 1-chome Chuo-ku, 104-8386, Tokyo, JP
:
MASUDA, Takaaki:
Yokohama-shiKanagawa, JP
:
MIYATA, Yoshiyuki:
Tokyo, JP
:
KANEDA, Hideo:
Tokyo, JP
:
2013046593:
8.3.2013:
JP
:
JP2013067952:
24.6.2013
:
C07D 409/06, A61K 31/4178, A61P 31/10